We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $1.85M
1-Year Est. Return 176.16%
This Fund
S&P 500
This Quarter Est. Return
-25.6%
1 Year Est. Return
+176.16%
3 Year Est. Return
+511.75%
5 Year Est. Return
+854.95%
10 Year Est. Return
+8,566.11%
AUM
$97.2M
AUM Growth
-$32.6M
Cap. Flow
+$1.04M
Cap. Flow %
1.07%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$1.2M
2
AGRX
Agile Therapeutics
AGRX
+$30.9K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$194K

Sector Composition

Rank Sector Weight
1 Healthcare 94.15%
2 Miscellaneous 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
1
Madrigal Pharmaceuticals
MDGL
$12.5B
$90.9M 93.55%
862,711
+8,658
+1% +$1.2M
CPXX
2
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$5.68M 5.85%
2,246,469
– –
COV
3
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$379K 0.39%
4,381
-2,191
-33% -$194K
AGRX
4
DELISTED
Agile Therapeutics
AGRX
$200K 0.21%
14
+2
+17% +$30.9K

Similar funds

1IC
1922 Investment Company Houston, Texas $1.89M AUM 15.39% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $1.91M AUM 81.42% 1-Year Est. Return
HGCK
HPC Germany & Co KG Potsdam, Germany $1.68M AUM 15.3% 1-Year Est. Return
CA
Cohalo Advisory Snoqualmie, Washington $1.65M AUM 11.44% 1-Year Est. Return
CAM
Creekmur Asset Management Morton, Illinois $2.07M AUM
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $1.56M AUM 25.68% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Caxton Corporation's Q3 2014 Portfolio in Review

As of Q3 2014, Caxton Corporation held 4 positions worth $97.2M, down 25% from $130M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 0%. Caxton Corporation opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 95% a quarter earlier, followed by Miscellaneous.

  • Caxton Corporation added most to Madrigal Pharmaceuticals in Q3 2014, an estimated $1.2M increase.
  • Caxton Corporation's biggest Q3 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $194K.
  • Caxton Corporation's ten largest holdings make up 100% of its $97.2M portfolio in Q3 2014.
  • Caxton Corporation opened 0 new positions and closed 0 in Q3 2014.
  • Caxton Corporation's portfolio value fell 25% quarter-over-quarter to $97.2M.

Based on Caxton Corporation's 13F filing for Q3 2014, filed 14 Nov 2014.